Safety of Anlotinib Capsules Combined with PD-1 Inhibitor Camrelizumab in the Third-Line Treatment of Advanced Non-Small-Cell Lung Cancer and Their Effect on Serum Tumor Markers
Table 1
Karnofsky behavior scoring criteria.
Physical condition
Points
Normal condition, no symptoms or signs
100
The patients could carry out normal activities, with mild symptoms and signs
90
The patients could carry out normal activities reluctantly, with some symptoms and signs
80
The patients could take care of themselves in daily life, but could not maintain normal life or activities
70
Sometimes, the patients needed help, but could generally take care of themselves
60
The patients needed others to look after them
50
The patients could not take care of themselves and needed special care
40
The patients could not take care of themselves at all
30
The patients had aggravated condition and required inpatient treatment
20
The patients were critically ill and close to death
